Collaborating at the Intersection of Art and Science
Deborah Davidson, founder of Catalyst Conversations
Todd Golub, founding core member, chief scientific officer, and director of the Cancer Program at the Broad Institute of MIT and Harvard; professor of Pediatrics at Harvard Medical School; Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute; investigator at Howard Hughes Medical Institute
Naoe Suzuki, artist in residence at Broad Institute
In a fascinating conversation between Broad Institute founding core member, Todd Golub, and artist-in-residence Naoe Suzuki, they explored ideation as a collaborative effort and the potential to enhance both the art and research.
ARCHEMY: a Chromatographics workshop
August 25, 2016
Dan Jay, Ph.D., Professor of Developmental, Molecular and Chemical Biology, Tufts University
Artist and scientist, Dan Jay described how he uses chromatography, a technique usually used for nucleic acid or protein purification, to make color abstractions. Participants were provided the opportunity to make their own sketches and process them in the laboratory. This activity challenged Broadies to think about a familiar technique in a different way. While the sketches were in the chromatography tanks, Broadies gathered for an informal reception and continued the conversation around the artwork, which, when processed, was installed in a temporary exhibit.
Focus on Rare Disease: from patients to genes, and from genes to treatments
April 11, 2016
A special seminar showcasing rare disease research in conjunction with the Rare Disease United Foundation’s “Beyond the Diagnosis” art exhibit.
Anna Greka, institute member, Broad Institute; director of the Glom-NExT Center for Glomerular Kidney Disease and Novel Experimental Therapeutics, Brigham and Women’s Hospital; assistant professor, Harvard Medical School
Lucas Kolasa, project director, Rare Disease United Foundation Beyond the Diagnosis Art Exhibit; co-founder, Eunoia Gallery
Elizabeth P. Henske, associate member, Broad Institute, director, Center for LAM Research and Clinical Care, Brigham and Women’s Hospital; medical oncologist, Dana-Farber Cancer Institute; professor of medicine, Harvard Medical School
Eric Minikel and Sonia Vallabh, Harvard Medical School graduate students, Schreiber Lab, Broad Institute
Broad Institute is committed to having an impact on patients with the estimated 7,000 types of rare disease. While the majority of rare diseases have a genetic basis, there are no FDA-approved treatments for 95% of rare disease patients. Broad Institute is committed to uncovering the genetic basis of rare diseases and to using those biological insights to drive new treatment strategies. With projects spanning multiple disease areas, Broad scientists are using new advances in genetics, functional genomics, computational biology and chemical biology to crack open rare diseases for the entire research community, and most importantly for patients.
Coinciding with the Broad opening of Beyond the Diagnosis, a traveling art exhibit featuring portraits of children with rare diseases, established and curated by the Rare Disease United Foundation, Broad hosted a special seminar focused on rare disease research at Broad Institute and at our partner institutions.
Beyond the Diagnosis was exhibited in the first floor lobby of the Stanley Building, 75 Ames, from April 6 - May 31, 2016.
Catalyst Conversations: On Beauty
Emily Eveleth, painter
David Tester, senior software engineer, Google; visiting scientist, Broad Institute
The notion of beauty invokes awe, pleasure, aspiration; we are taken outside of ourselves and returned. Painter Emily Eveleth and Senior Software Engineer David Tester, explored the idea of beauty and how it resonates and overlaps in both of their worlds.